Key Details
Annual ROE
160.08%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 31, 2024Recent annual earnings:
Apr 01, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
June 05, 2023Analyst ratings
Recent major analysts updates
17 June '21 HC Wainwright & Co.
Buy06 May '20 H.C. Wainwright
Neutral24 Oct '19 JP Morgan
Underweight14 Aug '19 H.C. Wainwright
Neutral02 Aug '19 Wedbush
Neutral02 Aug '19 Stifel
Hold23 May '19 Wedbush
Neutral11 Dec '18 Goldman Sachs
Sell05 Oct '18 Stifel Nicolaus
Hold23 Aug '18 Cantor Fitzgerald
NeutralScreeners with ACOR included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Acorda Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Acorda Therapeutics shares sink nearly 40% after bankruptcy filing
ACOR
Market Watch01 April 2024
Shares of Acorda Therapeutics ACOR, +1.96% fell late Monday after the company said it had filed for bankruptcy protection.
Acorda Therapeutics, Inc. (ACOR) Q3 2023 Earnings Call Transcript
ACOR
Seeking Alpha13 November 2023
Acorda Therapeutics, Inc. (NASDAQ:ACOR ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Tierney Saccavino - EVP, Corporate Communications Ron Cohen - Founder, CEO, President & Director Michael Gesser - CFO Conference Call Participants Operator Welcome to Acorda Therapeutics Third Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode.
3 Penny Stocks to Avoid as Interest Rates Rise in 2023
ACOR
InvestorPlace11 May 2023
Prudent investors are now forced to reassess their portfolios and risk profiles. Indeed, for those invested in penny stocks, the promise of substantial returns is great.
FAQ
- What is the primary business of Acorda Therapeutics?
- What is the ticker symbol for Acorda Therapeutics?
- Does Acorda Therapeutics pay dividends?
- What sector is Acorda Therapeutics in?
- What industry is Acorda Therapeutics in?
- What country is Acorda Therapeutics based in?
- When did Acorda Therapeutics go public?
- Is Acorda Therapeutics in the S&P 500?
- Is Acorda Therapeutics in the NASDAQ 100?
- Is Acorda Therapeutics in the Dow Jones?
- When was Acorda Therapeutics's last earnings report?
- When does Acorda Therapeutics report earnings?
- Should I buy Acorda Therapeutics stock now?
What is the primary business of Acorda Therapeutics?
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York. On April 1, 2024, Acorda Therapeutics, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
What is the ticker symbol for Acorda Therapeutics?
The ticker symbol for Acorda Therapeutics is NASDAQ:ACOR
Does Acorda Therapeutics pay dividends?
No, Acorda Therapeutics does not pay dividends
What sector is Acorda Therapeutics in?
Acorda Therapeutics is in the Healthcare sector
What industry is Acorda Therapeutics in?
Acorda Therapeutics is in the Drug Manufacturers - Specialty & Generic industry
What country is Acorda Therapeutics based in?
Acorda Therapeutics is headquartered in United States
When did Acorda Therapeutics go public?
Acorda Therapeutics's initial public offering (IPO) was on 10 February 2006
Is Acorda Therapeutics in the S&P 500?
No, Acorda Therapeutics is not included in the S&P 500 index
Is Acorda Therapeutics in the NASDAQ 100?
No, Acorda Therapeutics is not included in the NASDAQ 100 index
Is Acorda Therapeutics in the Dow Jones?
No, Acorda Therapeutics is not included in the Dow Jones index
When was Acorda Therapeutics's last earnings report?
Acorda Therapeutics's most recent earnings report was on 31 May 2024
When does Acorda Therapeutics report earnings?
The date for Acorda Therapeutics's next earnings report has not been announced yet
Should I buy Acorda Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions